HEADER HYDROLASE 11-JAN-18 6FGY TITLE CRYSTAL STRUCTURE OF HUMAN BACE-1 IN COMPLEX WITH AMINO-1,4-OXAZINE TITLE 2 COMPOUND 4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 5 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 6 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 7 EC: 3.4.23.46; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET24 KEYWDS OXAZINE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.-M.RONDEAU,E.BOURGIER REVDAT 2 20-JUN-18 6FGY 1 JRNL REVDAT 1 06-JUN-18 6FGY 0 JRNL AUTH S.J.VEENSTRA,H.RUEEGER,M.VOEGTLE,R.LUEOEND,P.HOLZER,K.HURTH, JRNL AUTH 2 M.TINTELNOT-BLOMLEY,M.FREDERIKSEN,J.M.RONDEAU,L.JACOBSON, JRNL AUTH 3 M.STAUFENBIEL,U.NEUMANN,R.MACHAUER JRNL TITL DISCOVERY OF AMINO-1,4-OXAZINES AS POTENT BACE-1 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 28 2195 2018 JRNL REFN ESSN 1464-3405 JRNL PMID 29764741 JRNL DOI 10.1016/J.BMCL.2018.05.003 REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1574315.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 57667 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2884 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.54 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8997 REMARK 3 BIN R VALUE (WORKING SET) : 0.2820 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 474 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2984 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 254 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.01000 REMARK 3 B22 (A**2) : 0.73000 REMARK 3 B33 (A**2) : -3.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.410 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.280 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.260 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 39.63 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FGY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1200008302. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS AUGUST 18, 2006 REMARK 200 DATA SCALING SOFTWARE : XSCALE AUGUST 18, 2006 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57667 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 61.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.250 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.04 REMARK 200 R MERGE FOR SHELL (I) : 0.47700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.740 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX 2002 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 1,500 IN WATER, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.02800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.10700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.36900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.10700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.02800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.36900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 45 REMARK 465 PRO A 46 REMARK 465 GLY A 206 REMARK 465 PHE A 207 REMARK 465 PRO A 208 REMARK 465 LEU A 209 REMARK 465 ASN A 210 REMARK 465 GLN A 211 REMARK 465 SER A 212 REMARK 465 GLU A 213 REMARK 465 VAL A 214 REMARK 465 LEU A 215 REMARK 465 ALA A 216 REMARK 465 THR A 437 REMARK 465 ASP A 438 REMARK 465 GLU A 439 REMARK 465 SER A 440 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 245 -79.77 -137.74 REMARK 500 ASN A 257 59.38 35.36 REMARK 500 CYS A 407 73.29 -103.61 REMARK 500 HIS A 410 137.52 -176.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue D9W A 501 DBREF 6FGY A 47 440 UNP P56817 BACE1_HUMAN 60 453 SEQADV 6FGY GLY A 45 UNP P56817 EXPRESSION TAG SEQADV 6FGY PRO A 46 UNP P56817 EXPRESSION TAG SEQRES 1 A 396 GLY PRO PHE VAL GLU MET VAL ASP ASN LEU ARG GLY LYS SEQRES 2 A 396 SER GLY GLN GLY TYR TYR VAL GLU MET THR VAL GLY SER SEQRES 3 A 396 PRO PRO GLN THR LEU ASN ILE LEU VAL ASP THR GLY SER SEQRES 4 A 396 SER ASN PHE ALA VAL GLY ALA ALA PRO HIS PRO PHE LEU SEQRES 5 A 396 HIS ARG TYR TYR GLN ARG GLN LEU SER SER THR TYR ARG SEQRES 6 A 396 ASP LEU ARG LYS GLY VAL TYR VAL PRO TYR THR GLN GLY SEQRES 7 A 396 LYS TRP GLU GLY GLU LEU GLY THR ASP LEU VAL SER ILE SEQRES 8 A 396 PRO HIS GLY PRO ASN VAL THR VAL ARG ALA ASN ILE ALA SEQRES 9 A 396 ALA ILE THR GLU SER ASP LYS PHE PHE ILE ASN GLY SER SEQRES 10 A 396 ASN TRP GLU GLY ILE LEU GLY LEU ALA TYR ALA GLU ILE SEQRES 11 A 396 ALA ARG PRO ASP ASP SER LEU GLU PRO PHE PHE ASP SER SEQRES 12 A 396 LEU VAL LYS GLN THR HIS VAL PRO ASN LEU PHE SER LEU SEQRES 13 A 396 GLN LEU CYS GLY ALA GLY PHE PRO LEU ASN GLN SER GLU SEQRES 14 A 396 VAL LEU ALA SER VAL GLY GLY SER MET ILE ILE GLY GLY SEQRES 15 A 396 ILE ASP HIS SER LEU TYR THR GLY SER LEU TRP TYR THR SEQRES 16 A 396 PRO ILE ARG ARG GLU TRP TYR TYR GLU VAL ILE ILE VAL SEQRES 17 A 396 ARG VAL GLU ILE ASN GLY GLN ASP LEU LYS MET ASP CYS SEQRES 18 A 396 LYS GLU TYR ASN TYR ASP LYS SER ILE VAL ASP SER GLY SEQRES 19 A 396 THR THR ASN LEU ARG LEU PRO LYS LYS VAL PHE GLU ALA SEQRES 20 A 396 ALA VAL LYS SER ILE LYS ALA ALA SER SER THR GLU LYS SEQRES 21 A 396 PHE PRO ASP GLY PHE TRP LEU GLY GLU GLN LEU VAL CYS SEQRES 22 A 396 TRP GLN ALA GLY THR THR PRO TRP ASN ILE PHE PRO VAL SEQRES 23 A 396 ILE SER LEU TYR LEU MET GLY GLU VAL THR ASN GLN SER SEQRES 24 A 396 PHE ARG ILE THR ILE LEU PRO GLN GLN TYR LEU ARG PRO SEQRES 25 A 396 VAL GLU ASP VAL ALA THR SER GLN ASP ASP CYS TYR LYS SEQRES 26 A 396 PHE ALA ILE SER GLN SER SER THR GLY THR VAL MET GLY SEQRES 27 A 396 ALA VAL ILE MET GLU GLY PHE TYR VAL VAL PHE ASP ARG SEQRES 28 A 396 ALA ARG LYS ARG ILE GLY PHE ALA VAL SER ALA CYS HIS SEQRES 29 A 396 VAL HIS ASP GLU PHE ARG THR ALA ALA VAL GLU GLY PRO SEQRES 30 A 396 PHE VAL THR LEU ASP MET GLU ASP CYS GLY TYR ASN ILE SEQRES 31 A 396 PRO GLN THR ASP GLU SER HET D9W A 501 24 HETNAM D9W ~{N}-[3-[(3~{R})-5-AZANYL-3-METHYL-2,6-DIHYDRO-1,4- HETNAM 2 D9W OXAZIN-3-YL]PHENYL]-5-BROMANYL-PYRIDINE-2-CARBOXAMIDE FORMUL 2 D9W C17 H17 BR N4 O2 FORMUL 3 HOH *254(H2 O) HELIX 1 AA1 PHE A 47 VAL A 51 5 5 HELIX 2 AA2 GLN A 101 SER A 105 5 5 HELIX 3 AA3 TYR A 171 ALA A 175 5 5 HELIX 4 AA4 PRO A 183 HIS A 193 1 11 HELIX 5 AA5 ASP A 228 SER A 230 5 3 HELIX 6 AA6 ASP A 264 TYR A 270 5 7 HELIX 7 AA7 LYS A 286 SER A 300 1 15 HELIX 8 AA8 PRO A 306 LEU A 311 1 6 HELIX 9 AA9 PRO A 324 PHE A 328 5 5 HELIX 10 AB1 LEU A 349 TYR A 353 1 5 HELIX 11 AB2 ASP A 359 SER A 363 5 5 HELIX 12 AB3 GLY A 382 GLU A 387 1 6 SHEET 1 AA1 9 ARG A 109 PRO A 118 0 SHEET 2 AA1 9 LYS A 123 SER A 134 -1 O LEU A 128 N LYS A 113 SHEET 3 AA1 9 GLY A 61 VAL A 68 -1 N THR A 67 O SER A 134 SHEET 4 AA1 9 LEU A 54 LYS A 57 -1 N ARG A 55 O TYR A 63 SHEET 5 AA1 9 VAL A 218 ILE A 224 -1 O VAL A 218 N GLY A 56 SHEET 6 AA1 9 PHE A 198 CYS A 203 -1 N GLN A 201 O SER A 221 SHEET 7 AA1 9 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 198 SHEET 8 AA1 9 ARG A 399 SER A 405 -1 O ALA A 403 N TYR A 390 SHEET 9 AA1 9 TYR A 232 PRO A 240 -1 N THR A 239 O ILE A 400 SHEET 1 AA213 ARG A 109 PRO A 118 0 SHEET 2 AA213 LYS A 123 SER A 134 -1 O LEU A 128 N LYS A 113 SHEET 3 AA213 THR A 142 ASP A 154 -1 O VAL A 143 N VAL A 133 SHEET 4 AA213 PHE A 86 GLY A 89 1 N VAL A 88 O ILE A 150 SHEET 5 AA213 GLY A 165 GLY A 168 -1 O ILE A 166 N ALA A 87 SHEET 6 AA213 GLN A 73 ASP A 80 1 N LEU A 78 O LEU A 167 SHEET 7 AA213 GLY A 61 VAL A 68 -1 N TYR A 62 O VAL A 79 SHEET 8 AA213 LEU A 54 LYS A 57 -1 N ARG A 55 O TYR A 63 SHEET 9 AA213 VAL A 218 ILE A 224 -1 O VAL A 218 N GLY A 56 SHEET 10 AA213 PHE A 198 CYS A 203 -1 N GLN A 201 O SER A 221 SHEET 11 AA213 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 198 SHEET 12 AA213 ARG A 399 SER A 405 -1 O ALA A 403 N TYR A 390 SHEET 13 AA213 TYR A 232 PRO A 240 -1 N THR A 239 O ILE A 400 SHEET 1 AA3 5 GLU A 248 VAL A 249 0 SHEET 2 AA3 5 SER A 273 VAL A 275 -1 O SER A 273 N VAL A 249 SHEET 3 AA3 5 THR A 379 MET A 381 1 O MET A 381 N ILE A 274 SHEET 4 AA3 5 LEU A 282 PRO A 285 -1 N ARG A 283 O VAL A 380 SHEET 5 AA3 5 ILE A 372 SER A 375 1 O SER A 373 N LEU A 284 SHEET 1 AA4 5 GLN A 259 ASP A 260 0 SHEET 2 AA4 5 ILE A 251 ILE A 256 -1 N ILE A 256 O GLN A 259 SHEET 3 AA4 5 ILE A 331 MET A 336 -1 O SER A 332 N GLU A 255 SHEET 4 AA4 5 GLN A 342 ILE A 348 -1 O ILE A 348 N ILE A 331 SHEET 5 AA4 5 ALA A 417 VAL A 423 -1 O GLU A 419 N ARG A 345 SHEET 1 AA5 3 VAL A 316 GLN A 319 0 SHEET 2 AA5 3 ASP A 365 PHE A 370 -1 O ASP A 366 N TRP A 318 SHEET 3 AA5 3 LEU A 354 PRO A 356 -1 N ARG A 355 O LYS A 369 SSBOND 1 CYS A 203 CYS A 407 1555 1555 2.03 SSBOND 2 CYS A 265 CYS A 430 1555 1555 2.03 SSBOND 3 CYS A 317 CYS A 367 1555 1555 2.04 CISPEP 1 SER A 70 PRO A 71 0 -0.89 CISPEP 2 ARG A 176 PRO A 177 0 1.56 CISPEP 3 TYR A 270 ASP A 271 0 6.33 CISPEP 4 GLY A 420 PRO A 421 0 -2.35 SITE 1 AC1 14 GLY A 59 GLN A 60 GLY A 61 LEU A 78 SITE 2 AC1 14 ASP A 80 TYR A 119 PHE A 156 ILE A 158 SITE 3 AC1 14 ILE A 166 ASP A 276 SER A 277 GLY A 278 SITE 4 AC1 14 THR A 280 ALA A 383 CRYST1 48.056 76.738 104.214 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020809 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013031 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009596 0.00000